Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Gastroenterology Clinics of North America|February 7, 2017
Biology of the Microbiome 1: Interactions with the Host Immune ResponseSylwia Smolinska, David Groeger, Liam O'Mahony
Plos One|March 28, 2015
Human dendritic cell DC-SIGN and TLR-2 mediate complementary immune regulatory activities in response to Lactobacillus rhamnosus JB-1Patrycja Konieczna, Elisa Schiavi, Mario Ziegler, et al.
Neurogastroenterology and Motility|September 30, 2022
Interactions between symptoms and psychological status in irritable bowel syndrome: An exploratory study of the impact of a probiotic combinationDavid Groeger, Eileen F Murphy, Hern Tze Tina Tan, et al.
The American Journal of Gastroenterology|April 22, 2010
Plasma cytokine profiles in females with irritable bowel syndrome and extra-intestinal co-morbidityPaul Scully, Declan P McKernan, John Keohane, et al.
Scientific Reports|February 14, 2024
Bifidobacterium longum 1714 improves sleep quality and aspects of well-being in healthy adults: a randomized, double-blind, placebo-controlled clinical trialElaine Patterson, Hern Tze Tina Tan, David Groeger, et al.
Experimental and Clinical Psychopharmacology|April 30, 2026
Effects of Bifidobacterium longum 1714 on low mood and related symptoms: A randomized, double-blind, placebo-controlled trialKelly M Seamans, Elaine Patterson, Caterina Holz, et al.
Gut Microbes|July 12, 2013
Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gutDavid Groeger, Liam O'Mahony, Eileen F Murphy, et al.
Inflammatory Bowel Diseases|June 9, 2016
Histamine Receptor 2 is Required to Suppress Innate Immune Responses to Bacterial Ligands in Patients with Inflammatory Bowel DiseaseSylwia Smolinska, David Groeger, Noelia Rodriguez Perez, et al.
Gut|November 5, 2011
Bifidobacterium infantis 35624 administration induces Foxp3 T regulatory cells in human peripheral blood: potential role for myeloid and plasmacytoid dendritic cellsPatrycja Konieczna, David Groeger, Mario Ziegler, et al.
Calcified Tissue International|January 3, 2021
An Exopolysaccharide Produced by Bifidobacterium longum 35624® Inhibits Osteoclast Formation via a TLR2-Dependent MechanismAlexandra Wallimann, Maria Hildebrand, David Groeger, et al.
Pageof 3